Merck KGaA (OTCMKTS:MKKGY) Stock Short Interest Report for September

Merck KGaA (OTCMKTS:MKKGY – Get Free Report) saw a large increase in short interest in September. As of September 30th, there was short interest totaling 39,149 shares, an increase of 1,031.1% from the September 15th total of 3,461 shares. Approximately 0.0% of the shares of the stock are short sold. Based on an average trading volume of 131,328 shares, the days-to-cover ratio is presently 0.3 days.

Wall Street Analyst Weigh In

Several brokerages recently commented on MKKGY. HSBC upgraded Merck KGaA to a “hold” rating in a research report on Monday, July 6th. Zacks Research lowered Merck KGaA from a “strong-buy” rating to a “hold” rating in a research report on Thursday, August 20th. Finally, UBS Group downgraded shares of Merck KGaA from a “strong-buy” rating to a “hold” rating in a research note on Thursday, August 20th. Six investment analysts have rated the stock with a Hold rating. According to data from MarketBeat, Merck KGaA presently has a consensus rating of “Hold”.

Get Merck KGaA alerts:

Read Our Latest Research Report on Merck KGaA

Merck KGaA Stock Up 0.9%

Merck KGaA stock traded up $0.28 during midday trading on Friday, reaching $31.06. The company’s stock had a trading volume of 136,237 shares, compared to its average volume of 157,301. The business has a 50-day simple moving average of $31.60 and a 200-day simple moving average of $30.09. The company has a market cap of $20.07 billion, a P/E ratio of 16.01, a P/E/G ratio of 2.94 and a beta of 0.95. Merck KGaA has a fifty-two week low of $23.73 and a fifty-two week high of $34.19. The company has a quick ratio of 1.09, a current ratio of 1.69 and a debt-to-equity ratio of 0.37.

Merck KGaA Company Profile

(Get Free Report)

Merck KGaA is a Germany-based science and technology company headquartered in Darmstadt. Founded in 1668, it is one of the world’s oldest pharmaceutical and chemical businesses. The company operates independently from Merck & Co, Inc, the U.S.-based company that uses the Merck name in the United States and Canada.

Merck KGaA operates through three primary business sectors: Life Science, Healthcare and Electronics. Its Life Science business supplies laboratory products, research tools, analytical technologies and bioprocessing solutions used by pharmaceutical and biotechnology companies, academic institutions and industrial laboratories.

Further Reading

• Five stocks we like better than Merck KGaA
• 3 Stocks Chopped in Half: Why These Drops May Be Structural, Not a Dip
• Home Depot and Lowe’s Hit 52-Week Lows—But Analysts Aren’t Giving Up
• Utilities Are Bouncing Back—These 2 Giants Could Signal the Next Big Sector Rally
• Q3 Earnings Could Blow Past Consensus—Be Ready for What Comes Next

Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.